IM Cannabis (IMCC) Enterprise Value (2019 - 2026)
IM Cannabis' (IMCC) quarterly Enterprise Value came in at -$785354.5 in Q1 2026, up 68.17% year-on-year from -$467009.6 in Q1 2025, and up 75.04% quarter-over-quarter from -$3.1 million in Q4 2025.
IM Cannabis (IMCC) Enterprise Value (2019 - 2026) Analysis & Trends
IM Cannabis' Enterprise Value history runs 8 years deep, the most recent figure standing at -$785354.5 for Q1 2026.
- On a quarterly basis, Enterprise Value rose 68.17% year-over-year to -$785354.5 in Q1 2026; TTM through Mar 2026 was -$785354.5, a 68.17% increase from a year earlier, with the FY2025 full-year figure at -$3.1 million, up 6.16% from the prior year.
- Enterprise Value rose to -$785354.5 in Q1 2026 per IMCC's latest filing, from -$3.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$184036.7 in Q2 2025 and bottomed at -$10.3 million in Q1 2022.
- The 5-year median for Enterprise Value is -$2.2 million (2024), against an average of -$2.9 million.
- Across the five-year window, Enterprise Value slumped 243.04% in 2024 and surged 91.81% in 2025, its largest moves.
- Year by year, Enterprise Value stood at -$2.7 million in 2022, then sank by 30.66% to -$3.6 million in 2023, then climbed by 8.07% to -$3.3 million in 2024, then advanced by 4.26% to -$3.1 million in 2025, then soared by 75.04% to -$785354.5 in 2026.
- Per Business Quant, the three latest IMCC Enterprise Value figures stand at -$785354.5 (Q1 2026), -$3.1 million (Q4 2025), and -$1.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | -1.86 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -3.74 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -1.94 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -4.05 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -2.15 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -33.59 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -1.80 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -1.32 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -428.00 Mn |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | -785,354.53 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -785,354.53 |
| Dec 31, 2025 | -3.15 Mn |
| Sep 30, 2025 | -1.44 Mn |
| Jun 30, 2025 | -184,036.69 |
| Mar 31, 2025 | -2.47 Mn |
| Dec 31, 2024 | -3.29 Mn |
| Sep 30, 2024 | -4.80 Mn |
| Jun 30, 2024 | -2.25 Mn |
| Mar 31, 2024 | -2.23 Mn |
| Dec 31, 2023 | -3.57 Mn |
| Sep 30, 2023 | -1.40 Mn |
| Jun 30, 2023 | -1.63 Mn |
| Mar 31, 2023 | -2.01 Mn |
| Dec 31, 2022 | -2.74 Mn |
| Sep 30, 2022 | -1.87 Mn |
| Jun 30, 2022 | -5.42 Mn |
| Mar 31, 2022 | -10.29 Mn |
| Dec 31, 2021 | -8.10 Mn |
| Sep 30, 2021 | -15.08 Mn |
| Jun 30, 2021 | -29.96 Mn |